2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …

SM Al-Khatib, WG Stevenson, MJ Ackerman… - Journal of the American …, 2018 - jacc.org
The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

What clinicians should know about the QT interval

SM Al-Khatib, NMA LaPointe, JM Kramer, RM Califf - Jama, 2003 - jamanetwork.com
ContextOf the several factors implicated in causing QT interval prolongation and torsades de
pointes, errors in the use of medications that may prolong this interval deserve special …

2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias

EM Cronin, FM Bogun, P Maury, P Peichl, M Chen… - EP …, 2019 - academic.oup.com
Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …

2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart …

RL Page, JA Joglar, MA Caldwell, H Calkins, JB Conti… - Circulation, 2016 - Am Heart Assoc
The recommendations listed in this guideline are, whenever possible, evidence based. An
extensive evidence review was conducted in April 2014 that included literature published …

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

RD Lopes, JH Alexander, SM Al-Khatib, J Ansell… - American heart …, 2010 - Elsevier
Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with
vitamin K antagonists (VKAs). Vitamin K antagonist use is limited, in part, by the high …

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - EP …, 2016 - academic.oup.com
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Systematic review of the incidence of sudden cardiac death in the United States

MH Kong, GC Fonarow, ED Peterson, AB Curtis… - Journal of the American …, 2011 - jacc.org
The need for consistent and current data describing the true incidence of sudden cardiac
arrest (SCA) and/or sudden cardiac death (SCD) was highlighted during the most recent …

Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure

AF Hernandez, GC Fonarow, L Liang, SM Al-Khatib… - Jama, 2007 - jamanetwork.com
ContextPractice guidelines recommend implantable cardioverter-defibrillator (ICD) therapy
for patients with heart failure and left ventricular ejection fraction of 30% or less. The …

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access …

DJ Whellan, KT Ousdigian, SM Al-Khatib, W Pu… - Journal of the American …, 2010 - jacc.org
Objectives: We sought to determine the utility of combined heart failure (HF) device
diagnostic information to predict clinical deterioration of HF in patients with systolic left …

Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials

JP Piccini, RD Lopes, MH Kong… - Circulation …, 2009 - Am Heart Assoc
Background—Catheter ablation is an established yet evolving nonpharmacologic
intervention for the maintenance of sinus rhythm in patients with atrial fibrillation (AF). The …